AVaTAR MedTech
Developer of a surgical method and supporting single-use instruments for reconstructing aortic and pulmonary semilunar valves using the patient’s own tissue. The company focuses on pediatric and adult applications, combining computational modelling, rapid prototyping and preclinical/clinical evaluation to deliver a standardized, growth-accommodating valve reconstruction workflow and devices.
Industries
Nr. of Employees
small (1-50)
Products
Autologous trileaflet semilunar valve reconstruction method
A surgical procedure to create a trileaflet neo-valve from the patient’s own tissue, designed to be sufficient and to accommodate growth in pediatric patients.
Single-use surgical instrument set for semilunar valve reconstruction
A set of engineered single-use instruments to assist surgeons in creating and implanting a reconstructed valve from autologous tissue in a standardized, semi-automated workflow.
AVaTAR MedTech Semilunar Heart Valve Reconstruction
An innovative medical technology and surgical reconstruction method for semilunar heart valves, developed to provide life-saving alternatives for pediatric patients with heart valve diseases.
AVaTAR Pediatric
Specialized medical devices and surgical method for valve reconstruction in children, featuring an oversized design to accommodate growth and small sizing.
AVaTAR Adult
Medical devices and surgical method for adult valve repair and replacement, offering an alternative to mechanical valves and bioprostheses without lifelong anticoagulation.
Autologous trileaflet semilunar valve reconstruction method
A surgical procedure to create a trileaflet neo-valve from the patient’s own tissue, designed to be sufficient and to accommodate growth in pediatric patients.
Single-use surgical instrument set for semilunar valve reconstruction
A set of engineered single-use instruments to assist surgeons in creating and implanting a reconstructed valve from autologous tissue in a standardized, semi-automated workflow.
AVaTAR MedTech Semilunar Heart Valve Reconstruction
An innovative medical technology and surgical reconstruction method for semilunar heart valves, developed to provide life-saving alternatives for pediatric patients with heart valve diseases.
AVaTAR Pediatric
Specialized medical devices and surgical method for valve reconstruction in children, featuring an oversized design to accommodate growth and small sizing.
AVaTAR Adult
Medical devices and surgical method for adult valve repair and replacement, offering an alternative to mechanical valves and bioprostheses without lifelong anticoagulation.
Services
On-site surgical workshops and usability evaluations for surgeons to train on the reconstruction method and provide feedback for device and workflow refinement.
On-site surgical workshops and usability evaluations for surgeons to train on the reconstruction method and provide feedback for device and workflow refinement.
Expertise Areas
- Pediatric cardiac surgery and semilunar valve reconstruction
- Medical device design and rapid prototyping
- Preclinical testing and device validation
- Clinical implementation and surgical workflow standardization
Key Technologies
- Additive manufacturing / 3D printing
- Injection molding with medical-grade plastics
- Hydrodynamic flow-loop testing
- Echocardiographic performance assessment
News & Updates
Engaged an SMU MBA consulting team to analyse market opportunities and commercialization strategy.
Participated in a MedTech development conference to connect with investors and industry leaders.
Presented pediatric cardiovascular innovation at UCSF Mission Bay and connected with life sciences stakeholders.
Award supporting development and commercialization of autologous trileaflet valve reconstruction tools for children.
Named winner at a regional innovation competition for valve reconstruction technology.
Completed a program strengthening regulatory strategy, value proposition and commercialization roadmap for pediatric valve solutions.
Engaged an SMU MBA consulting team to analyse market opportunities and commercialization strategy.
Participated in a MedTech development conference to connect with investors and industry leaders.
Presented pediatric cardiovascular innovation at UCSF Mission Bay and connected with life sciences stakeholders.
Award supporting development and commercialization of autologous trileaflet valve reconstruction tools for children.
Named winner at a regional innovation competition for valve reconstruction technology.
Completed a program strengthening regulatory strategy, value proposition and commercialization roadmap for pediatric valve solutions.